Clinical trial
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic…
NCT00106691 · GTx, Industry · Completed
Key facts
| NCT number | NCT00106691 |
|---|---|
| Title | Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN) |
| Lead sponsor | GTx, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Preneoplastic Conditions, Prostatic Intraepithelial Neoplasia |
| Intervention type | Drug |
| Interventions | Toremifene 20 mg, Placebo |
| Enrollment | 1,589 |
| Start date | Jan 1, 2005 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Mar 30, 2005 |
| Last update posted | Jun 12, 2023 |
| Countries | Argentina, Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: